Congenica Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 77

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.64M

  • Investors
  • 21

Congenica General Information

Description

Developer of a clinical genome interpretation technology designed to identify genetic diseases in patients. The company's medical technology processes genomic datasets to detect mutations by filtering clinically relevant variants and deep clinical phenotyping, enabling clinicians and researchers to interrogate the human genome to identify disease-causing variants.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Outcome Management (Healthcare)
Corporate Office
  • Wellcome Genome Campus
  • BIC Building
  • Cambridge CB10 1DR
  • England, United Kingdom
+44 01223 000000

Congenica Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Congenica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Grant 01-May-2021 $2.64M 000.00 Completed Generating Revenue
12. Later Stage VC (Series C) 09-Nov-2020 000.00 000.00 00000 Completed Generating Revenue
11. Later Stage VC (Series B) 30-Apr-2019 000.00 000.00 000.00 Completed Generating Revenue
9. Grant 01-Sep-2018 00000 00.000 Completed Generating Revenue
8. Later Stage VC 01-Mar-2017 00.000 Completed Generating Revenue
7. Secondary Transaction - Private 01-Jan-2016 00.000 Completed Generating Revenue
6. Grant 29-Sep-2015 00000 00.000 Completed Generating Revenue
5. Early Stage VC (Series A) 01-Apr-2015 00.000 00.000 00.00 Completed Generating Revenue
4. Grant 11-Mar-2015 $4.59M $3.27M Completed Startup
3. Seed Round 05-Dec-2014 $2.45M $3.27M Completed Startup
To view Congenica’s complete valuation and funding history, request access »

Congenica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
B Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
B Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 4,396,070 $0.001301 $0.65 $0.65 1x $0.65 7.66%
A Ordinary 2,553,500 $0.001301 $0.25 $0.25 1x $0.25 4.45%
To view Congenica’s complete cap table history, request access »

Congenica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical genome interpretation technology designed to identify genetic diseases in patients. The company'
Decision/Risk Analysis
Cambridge, United Kingdom
77 As of 2024
000.00
0000000000 000.00

000000

illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
0000000000000 000000
Creve Coeur, MO
000 As of 0000
000.00
000000000000 000.00

000000

ncididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
0000000000000 000000
New York, NY
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Congenica Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PierianDx Private Equity-Backed Creve Coeur, MO 000 000.00 000000000000 000.00
Phosphorus (Decision/Risk Analysis) Formerly VC-backed New York, NY 00 000.00 000000&0 000.00
Genuity Science Formerly VC-backed Dublin, Ireland 000 00000 000000&0 00000
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD 000 00000 000000&0 00000
Genomenon Venture Capital-Backed Ann Arbor, MI 000 000.00 00000000000 000.00
You’re viewing 5 of 36 competitors. Get the full list »

Congenica Executive Team (22)

Name Title Board Seat Contact Info
Rob Denison Chief Executive Officer & Board Member
Sachin Saxena Chief Technology Officer
Helen Savage Acting Chief Scientific Officer
Richard Durbin Ph.D Informatics Director
Peter Fox Chief Architect
You’re viewing 5 of 22 executive team members. Get the full list »

Congenica Board Members (16)

Name Representing Role Since
Alastair Kilgour Parkwalk Advisors Board Member 000 0000
Andrew Richards Ph.D Cambridge Innovation Capital Chairman 000 0000
Matthew Hurles Ph.D Congenica Co-Founder, Scientific Director & Board Member 000 0000
Michael Anstey Ph.D Cambridge Innovation Capital Board Member 000 0000
Ridhita Gupta Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Congenica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Congenica Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Downing Asset Manager Minority 000 0000 000000 0
IDO Investments Venture Capital Minority 000 0000 000000 0
Image Frame Investment Corporate Venture Capital Minority 000 0000 000000 0
Kenneth Hertz Angel (individual) Minority 000 0000 000000 0
Legal & General Group Corporation Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Congenica FAQs

  • When was Congenica founded?

    Congenica was founded in 2012.

  • Who is the founder of Congenica?

    Richard Durbin Ph.D, Matthew Hurles Ph.D, Thomas Weaver Ph.D, and Nicholas Lench Ph.D are the founders of Congenica.

  • Who is the CEO of Congenica?

    Rob Denison is the CEO of Congenica.

  • Where is Congenica headquartered?

    Congenica is headquartered in Cambridge, United Kingdom.

  • What is the size of Congenica?

    Congenica has 77 total employees.

  • What industry is Congenica in?

    Congenica’s primary industry is Decision/Risk Analysis.

  • Is Congenica a private or public company?

    Congenica is a Private company.

  • What is Congenica’s current revenue?

    The current revenue for Congenica is 00000.

  • How much funding has Congenica raised over time?

    Congenica has raised $89.8M.

  • Who are Congenica’s investors?

    Downing, IDO Investments, Image Frame Investment, Kenneth Hertz, and Legal & General Group are 5 of 21 investors who have invested in Congenica.

  • Who are Congenica’s competitors?

    PierianDx, Phosphorus (Decision/Risk Analysis), Genuity Science, Personal Genome Diagnostics, and Genomenon are some of the 36 competitors of Congenica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »